Lantheus Holdings

Lantheus Holdings develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The company's products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, technologists and sonographers working in a variety of clinical settings. The company sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The company's portfolio of commercial products is diversified across a range of imaging modalities, which include DEFINITY, TechneLite, Xenon Xe 133 Gas, Neurolite, and Cardiolite, among others.
  • TickerLNTH
  • ISINUS5165441032
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ValuEngine Rating and Forecast Report for LNTH

ResearchPool Subscriptions

Get the most out of your insights

Get in touch